JPMorgan Healthcare Leaders ETF (JDOC) Holdings
JDOC holdings summary
as of Oct 24, 2026- Holdings
- 52 positions listed
- Top 10 weight
- 50.5% of net assets
- Effective holdings
- 27 equal-weight equivalent
- Largest holding
- ABBV 8.49% AbbVie Inc.
- Annual turnover
- 0.0% of the portfolio traded
All JDOC holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | Healthcare | 8.49% | $814,584.53 | $504.37B | 80.6 |
| 2 | LLY | Eli Lilly and Company | Healthcare | 8.38% | $804,648.35 | $1.12T | 42.2 |
| 3 | UNH | UnitedHealth Group Incorporated | Healthcare | 5.57% | $535,085.01 | $360.32B | 25.8 |
| 4 | NOVN | Novartis AG | Healthcare | 4.65% | $446,676.99 | — | — |
| 5 | JNJ | Johnson & Johnson | Healthcare | 4.63% | $444,699.35 | $615.87B | 38.8 |
| 6 | MRK | Merck & Co., Inc. | Healthcare | 4.55% | $437,096.01 | $360.08B | 115.8 |
| 7 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 4.49% | $431,220.71 | $255.13B | 37.1 |
| 8 | AZN | AstraZeneca PLC | Healthcare | 4.18% | $401,172.15 | — | — |
| 9 | DHR | Danaher Corporation | Healthcare | 2.96% | $283,906.00 | $161.01B | 40.8 |
| 10 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.62% | $251,668.61 | $150.74B | 48.9 |
| 11 | 0QIU | Novo Nordisk A/S Class B | Other | 2.53% | $243,009.26 | — | — |
| 12 | IQV | IQVIA Holdings Inc. | Healthcare | 2.30% | $220,448.84 | $43.93B | 33.2 |
| 13 | SYK | Stryker Corporation | Healthcare | 2.08% | $199,808.46 | $113.02B | 30.5 |
| 14 | ARGX | Argen-X | Healthcare | 2.06% | $198,022.83 | — | — |
| 15 | COR | Cencora | Healthcare | 2.03% | $195,334.78 | $65.06B | 25.3 |
| 16 | 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | 1.98% | $190,448.29 | — | — |
| 17 | ROP | Roche Holding AG | Healthcare | 1.94% | $186,301.02 | — | — |
| 18 | HUM | Humana Inc. | Healthcare | 1.91% | $183,651.37 | $49.61B | 39.1 |
| 19 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.81% | $173,542.38 | $122.05B | 13.2 |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.80% | $173,254.38 | $81.41B | 19.6 |
| 21 | BIIB | Biogen Inc. | Healthcare | 1.79% | $171,689.55 | $34.37B | 41.3 |
| 22 | EW | Edwards Lifesciences Corporation | Healthcare | 1.65% | $158,594.91 | $49.92B | 51.5 |
| 23 | CNC | Centene Corporation | Healthcare | 1.51% | $144,617.05 | $34.16B | — |
| 24 | HCA | HCA Healthcare, Inc. | Healthcare | 1.48% | $141,813.80 | $99.34B | 15.4 |
| 25 | TEVA | Teva Pharmaceutical Industries Ltd | Healthcare | 1.45% | $138,895.35 | — | — |
| 26 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.44% | $138,492.14 | $126.66B | 28.9 |
| 27 | CAH | Cardinal Health, Inc. | Healthcare | 1.42% | $136,082.49 | $58.83B | 35.1 |
| 28 | BAYN | Bayer AG NA | Healthcare | 1.40% | $133,932.06 | — | — |
| 29 | SDZ | Sandoz Group AG | Healthcare | 1.37% | $131,100.00 | — | — |
| 30 | GEN | Genmab A/S | Other | 1.13% | $108,433.99 | — | — |
| 31 | ZTS | Zoetis Inc. | Healthcare | 1.11% | $106,235.55 | $32.80B | 13.1 |
| 32 | CRL | Charles River Laboratories International, Inc. | Healthcare | 1.06% | $101,877.07 | $14.46B | — |
| 33 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 1.00% | $95,579.35 | $18.12B | 23.1 |
| 34 | FRE | Fresenius SE & Co. KGaA | Healthcare | 0.93% | $89,425.64 | — | — |
| 35 | ABT | Abbott Laboratories | Healthcare | 0.83% | $79,230.25 | $181.50B | 33.8 |
| 36 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.77% | $74,094.16 | $13.79B | 19.9 |
| 37 | IRON | Disc Medicine, Inc. | Healthcare | 0.71% | $67,873.24 | $2.18B | — |
| 38 | CTEC | ConvaTec Group PLC | Healthcare | 0.65% | $62,305.14 | — | — |
| 39 | INSM | Insmed Incorporated | Healthcare | 0.64% | $61,306.72 | $21.02B | — |
| 40 | MDT | Medtronic plc | Healthcare | 0.64% | $61,066.72 | $121.20B | 23.3 |
| 41 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.61% | $58,772.28 | $12.98B | — |
| 42 | PTCT | PTC Therapeutics, Inc. | Healthcare | 0.52% | $49,719.31 | $4.94B | — |
| 43 | GSK | GSK plc | Healthcare | 0.51% | $49,258.50 | — | — |
| 44 | DYN | Dyne Therapeutics, Inc. | Healthcare | 0.48% | $45,984.84 | $2.66B | — |
| 45 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 0.48% | $45,725.64 | $7.47B | — |
| 46 | ALGN | Align Technology, Inc. | Healthcare | 0.43% | $41,280.76 | $10.46B | 25.6 |
| 47 | LBRX | LB Pharmaceuticals Inc | Healthcare | 0.42% | $40,330.34 | $1.19B | 367.4 |
| 48 | BSX | Boston Scientific Corporation | Healthcare | 0.38% | $36,730.27 | $64.33B | 18.0 |
| 49 | LEGN | Legend Biotech Corporation | Healthcare | 0.31% | $30,163.75 | $3.59B | — |
| 50 | APMD | Apnimed, Inc. | Healthcare | 0.25% | $23,837.24 | $739.4M | 2.5 |
| 51 | SRT3 | Sartorius Aktiengesellschaft | Healthcare | 0.10% | $9,484.97 | — | — |
| 52 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 0.10% | $9,302.57 | $31.02B | 39.1 |
Weights as a percentage of net assets. Value held = weight × net assets ($9.6M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
JDOC sector breakdown
Sum of the weights of the holdings in each sector.
JDOC top industries
JDOC overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IXJ | iShares Global Healthcare ETF | 57.5% | 37 of 106 | 0.42% |
| TRUH | VanEck Healthcare TruSector ETF | 55.4% | 27 of 60 | — |
| XLV | Health Care Select Sector SPDR Fund | 54.7% | 27 of 60 | 0.09% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 53.1% | 24 of 46 | 0.76% |
| IYH | iShares U.S. Healthcare ETF | 52.9% | 29 of 99 | 0.39% |
| FHLC | Fidelity MSCI Health Care ETF | 51.5% | 36 of 334 | 0.07% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the JDOC portfolio
JPMorgan Healthcare Leaders ETF holds 52 positions. The ten largest make up 50.5% of the fund and the top 50 98.3%, so it behaves like a portfolio of about 27 equally weighted stocks. The biggest positions are AbbVie Inc. (8.49%), Eli Lilly and Company (8.38%), UnitedHealth Group Incorporated (5.57%), Novartis AG (4.65%), Johnson & Johnson (4.63%).
By sector, Healthcare is 94.9%, Other is 3.7%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: JDOC chart, JDOC performance, JDOC dividends, JDOC valuation, JDOC overview.
JDOC holdings FAQ
How many holdings does JDOC have?
JDOC holds 52 positions as of October 24, 2026.
What are the top 10 holdings of JDOC?
The ten largest holdings are AbbVie Inc. (8.49%), Eli Lilly and Company (8.38%), UnitedHealth Group Incorporated (5.57%), Novartis AG (4.65%), Johnson & Johnson (4.63%), Merck & Co., Inc. (4.55%), Thermo Fisher Scientific Inc. (4.49%), AstraZeneca PLC (4.18%), Danaher Corporation (2.96%), Intuitive Surgical, Inc. (2.62%). Together they are 50.5% of the fund.
What percentage of JDOC is AbbVie Inc.?
AbbVie Inc. is the largest holding at 8.49% of net assets, about $814,584.53 of the fund's $9.6M.
How concentrated is JDOC?
The top 10 holdings are 50.5% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) JDOC behaves like a portfolio of about 27 equally weighted stocks.